related documents
- A phase 2, single agent study of Cl-1033 administered at two doses in ovarian cancer patients who failed platinum therapy. Conferences
- A phase II study of intravenous DX-8951f administered daily for five days every three weeks to patients with previously untreated metastatic gastric cancer. Conferences
- A phase II trial of the proteosome inhibitor PS-341 in patients with metastatic colorectal cancer Conferences
- A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care. Conferences
- A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A National Cancer Institute of Cancer Clinical Trials Group Study. Conferences
- Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen Conferences
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I). Conferences
- Characteristics of out-of-pocket costs for cancer patients in Ontario, Canada Conferences
- Chemo-radiotherapy versus radiotherapy alone for nasopharyngeal carcinoma: A meta-analysis of 78 randomized controlled trials (RCTs) from English and non-English databases. Conferences
- Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic Regimens Conferences
- Comparison of outcomes of phase II trials (P2Ts) and subsequent randomized control trials (RCTs) using identical therapeutic regimens. Conferences
- Dexamethasone (dex) maintenance versus observation (obs) in patients with previously untreated multiple myeloma: A National Cancer Institute of Canada Clinical Trials Group Study: MY.7. Conferences
- Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies. Conferences
- Frequency of axillary node dissection and chemotherapy in breast cancer patients over 60 years of age compared with those younger than 60 years of age. Conferences
- Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA).: Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCICCTG and the EORTC GCG. Conferences
- Ontario Cancer Research Ethics Board (OCREB): A central research ethics board initiative. Conferences
- Patterns of trastuzumab (T) use in three Canadian provinces. Conferences
- Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial Conferences
- Phase I study of a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 4 (TRAIL-R1) in subjects with advanced solid malignancies or non-Hodgkin's lymphoma (NHL) Conferences
- Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCICCTG IND-148. Conferences
- Prognostic factors in early stage head and neck squamous cell carcinoma (HNSCC) patients in a prospective clinical trial. Conferences
- Prognostication using serum levels of components of the folate metabolic pathway in patients (PTS) treated with capecitabine for advanced colorectal cancer (ACRC). Conferences
- Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18. Conferences
- Retrospective analysis of treatment practices for elderly cancer patients (Pts) in Ontario, Canada Conferences
- Safety and efficacy of DHA-paclitaxel (TXP) in non-small cell lung cancer (NSCLC). Conferences
- Slow intravenous infusion of PV701, an oncolytic virus: Final results of a phase I study Conferences
- Supportive care in cancer. Who does what? Conferences
- The intensity of CEACAM-1 expression in melanoma patients and the timing of treatment with recombinant human interferon & 2b showed correlation with survival. Conferences
- Thromboembolism (TE) in children with acute lymphoblastic leukemia (ALL) treated on Dana Farber Cancer Institute (DFCI) protocols: Effect of dose and type (prednisone versus dexamethasone) of steroids used. Conferences
- Tolerability of the Intergroup 0099 regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status. Conferences
- Zoledronic acid reduces the need for radiation to bone in patients with breast or prostate cancer metastatic to bone: A survival-adjusted cumulative incidence analysis. Conferences